Clearmind Medicine Welcomes President Trump’s Executive Order as a Historic Catalyst for Psychedelic Innovation and Veteran Mental Health Care
Clearmind Medicine Inc., a Nasdaq-listed clinical-stage psychedelic biotech company, welcomes President Trump's Executive Order focused on accelerating medical treatments for serious mental illness by prioritizing FDA review of certain psychedelic drugs. The order expands patient access pathways and aligns with Clearmind's mission to develop non-ha…